{"title":"复发性尿路感染患者产生耐碳青霉烯ndm的大肠杆菌的分子特征。","authors":"Liang Chen, Zeqiang Xie, Jiyong Jian","doi":"10.7754/Clin.Lab.2024.241040","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to clarify the microbiological characteristics of carbapenem-resistant Escherichia coli (CRECO) due to New Delhi metallo-β-lactamase (NDM)-producing from recurrent urinary tract infection (RUTI) patients.</p><p><strong>Methods: </strong>CRECO isolates were isolated from the urine of RUTI patients, identified with VITEK 2 compact system, and confirmed by MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was performed with VITEK 2 compact system and Kirby-Bauer (K-B) method. Disk diffusion was used for extended spectrum beta-lactamase (ESBL) test. Phenotypic assays, including modified Hodge test (MHT), EDTA-modified carbapenem inactivation method (eCIM), and modified carbapenem inactivation method (mCIM), were performed to screen the carba-penemase. The antibiotic resistance genes were detected by polymerase chain reaction (PCR). Multilocus sequence typing (MLST) was performed for molecular typing of the strains.</p><p><strong>Results: </strong>Among 63 CRECO strains, 22 (34.9%) strains were NDM-positive, in which NDM-5 accounted for 68.2% (15/22), NDM-1 accounted for 22.7% (5/22), and NDM-3 accounted for 9.1% (2/22). Among the 22 strains, 20 (90.9%) strains were co-carrying ESBLs genes, 12 (54.6%) strains were co-carrying blaCTX and blaTEM, 8 (36.4%) strains were co-carrying blaCTX or blaTEM, and 5 strains were co-carrying AmpC genes. BlaCMY-6 and blaCMY-156 ac-counted for 9.1% (2/22) and blaCMY-42 and blaDHA-1 accounted for 4.5% (1/22). Ten (45.5%) strains were co-carrying quinolone resistance genes. Three (13.6%) strains were co-carrying colistin resistance genes mcr-1. Six (27.3%) strains showed OmpF-expressed loss. Fourteen strains were positive and 8 strains were negative in the MHT, but mCIM and eCIM were both positive; the results of double-disc synergy method for detection of ESBLs were all negative in NDM-positive CRECO strains. The NDM-producing CRECO strains showed high-resistant rate to most antibiotics.</p><p><strong>Conclusions: </strong>The antibiotic resistance mechanisms of NDM-positive CRECO are the coexistence of multiple resistance genes and/or the loss of or lesser expression of OMP. The emergence of mcr-1 gene in CRECO should be paid more attention by clinicians and microbiologists. Further surveillance should be strengthened to study the microbiological characteristics in order to control infection caused by NDM-positive CRECO better.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 5","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Molecular Characterization of Carbapenem-Resistant NDM-Producing Escherichia Coli from Recurrent Urinary Tract Infection Patients.\",\"authors\":\"Liang Chen, Zeqiang Xie, Jiyong Jian\",\"doi\":\"10.7754/Clin.Lab.2024.241040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>This study aimed to clarify the microbiological characteristics of carbapenem-resistant Escherichia coli (CRECO) due to New Delhi metallo-β-lactamase (NDM)-producing from recurrent urinary tract infection (RUTI) patients.</p><p><strong>Methods: </strong>CRECO isolates were isolated from the urine of RUTI patients, identified with VITEK 2 compact system, and confirmed by MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was performed with VITEK 2 compact system and Kirby-Bauer (K-B) method. Disk diffusion was used for extended spectrum beta-lactamase (ESBL) test. Phenotypic assays, including modified Hodge test (MHT), EDTA-modified carbapenem inactivation method (eCIM), and modified carbapenem inactivation method (mCIM), were performed to screen the carba-penemase. The antibiotic resistance genes were detected by polymerase chain reaction (PCR). Multilocus sequence typing (MLST) was performed for molecular typing of the strains.</p><p><strong>Results: </strong>Among 63 CRECO strains, 22 (34.9%) strains were NDM-positive, in which NDM-5 accounted for 68.2% (15/22), NDM-1 accounted for 22.7% (5/22), and NDM-3 accounted for 9.1% (2/22). Among the 22 strains, 20 (90.9%) strains were co-carrying ESBLs genes, 12 (54.6%) strains were co-carrying blaCTX and blaTEM, 8 (36.4%) strains were co-carrying blaCTX or blaTEM, and 5 strains were co-carrying AmpC genes. BlaCMY-6 and blaCMY-156 ac-counted for 9.1% (2/22) and blaCMY-42 and blaDHA-1 accounted for 4.5% (1/22). Ten (45.5%) strains were co-carrying quinolone resistance genes. Three (13.6%) strains were co-carrying colistin resistance genes mcr-1. Six (27.3%) strains showed OmpF-expressed loss. Fourteen strains were positive and 8 strains were negative in the MHT, but mCIM and eCIM were both positive; the results of double-disc synergy method for detection of ESBLs were all negative in NDM-positive CRECO strains. The NDM-producing CRECO strains showed high-resistant rate to most antibiotics.</p><p><strong>Conclusions: </strong>The antibiotic resistance mechanisms of NDM-positive CRECO are the coexistence of multiple resistance genes and/or the loss of or lesser expression of OMP. The emergence of mcr-1 gene in CRECO should be paid more attention by clinicians and microbiologists. Further surveillance should be strengthened to study the microbiological characteristics in order to control infection caused by NDM-positive CRECO better.</p>\",\"PeriodicalId\":10384,\"journal\":{\"name\":\"Clinical laboratory\",\"volume\":\"71 5\",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical laboratory\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7754/Clin.Lab.2024.241040\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241040","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Molecular Characterization of Carbapenem-Resistant NDM-Producing Escherichia Coli from Recurrent Urinary Tract Infection Patients.
Background: This study aimed to clarify the microbiological characteristics of carbapenem-resistant Escherichia coli (CRECO) due to New Delhi metallo-β-lactamase (NDM)-producing from recurrent urinary tract infection (RUTI) patients.
Methods: CRECO isolates were isolated from the urine of RUTI patients, identified with VITEK 2 compact system, and confirmed by MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was performed with VITEK 2 compact system and Kirby-Bauer (K-B) method. Disk diffusion was used for extended spectrum beta-lactamase (ESBL) test. Phenotypic assays, including modified Hodge test (MHT), EDTA-modified carbapenem inactivation method (eCIM), and modified carbapenem inactivation method (mCIM), were performed to screen the carba-penemase. The antibiotic resistance genes were detected by polymerase chain reaction (PCR). Multilocus sequence typing (MLST) was performed for molecular typing of the strains.
Results: Among 63 CRECO strains, 22 (34.9%) strains were NDM-positive, in which NDM-5 accounted for 68.2% (15/22), NDM-1 accounted for 22.7% (5/22), and NDM-3 accounted for 9.1% (2/22). Among the 22 strains, 20 (90.9%) strains were co-carrying ESBLs genes, 12 (54.6%) strains were co-carrying blaCTX and blaTEM, 8 (36.4%) strains were co-carrying blaCTX or blaTEM, and 5 strains were co-carrying AmpC genes. BlaCMY-6 and blaCMY-156 ac-counted for 9.1% (2/22) and blaCMY-42 and blaDHA-1 accounted for 4.5% (1/22). Ten (45.5%) strains were co-carrying quinolone resistance genes. Three (13.6%) strains were co-carrying colistin resistance genes mcr-1. Six (27.3%) strains showed OmpF-expressed loss. Fourteen strains were positive and 8 strains were negative in the MHT, but mCIM and eCIM were both positive; the results of double-disc synergy method for detection of ESBLs were all negative in NDM-positive CRECO strains. The NDM-producing CRECO strains showed high-resistant rate to most antibiotics.
Conclusions: The antibiotic resistance mechanisms of NDM-positive CRECO are the coexistence of multiple resistance genes and/or the loss of or lesser expression of OMP. The emergence of mcr-1 gene in CRECO should be paid more attention by clinicians and microbiologists. Further surveillance should be strengthened to study the microbiological characteristics in order to control infection caused by NDM-positive CRECO better.
期刊介绍:
Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.